{
    "organizations": [],
    "uuid": "2c5d3f0f695cabc12d14db74a7157fbbf72e7dfe",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-casi-pharmaceuticals-q4-loss-per-s/brief-casi-pharmaceuticals-q4-loss-per-share-0-08-idUSASC09U5V",
    "ord_in_thread": 0,
    "title": "CASI Pharmaceuticals Q4 Loss Per Share $0.08",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - CASI Pharmaceuticals Inc:\n* CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.08 * AS OF DECEMBER 31, 2017, CASI HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $43.5 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T19:18:00.000+03:00",
    "crawled": "2018-03-30T13:29:10.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "casi",
        "pharmaceutical",
        "inc",
        "casi",
        "pharmaceutical",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "december",
        "casi",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}